Moore Capital Management LP Sells 25,000 Shares of SPDR S&P Biotech ETF $XBI

Moore Capital Management LP decreased its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 10.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 225,000 shares of the exchange traded fund’s stock after selling 25,000 shares during the period. Moore Capital Management LP owned about 0.34% of SPDR S&P Biotech ETF worth $27,434,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Banco Bilbao Vizcaya Argentaria S.A. bought a new position in SPDR S&P Biotech ETF during the fourth quarter worth about $5,091,000. Align Financial LLC bought a new position in SPDR S&P Biotech ETF during the fourth quarter worth about $3,761,000. WS Management Lllp lifted its stake in SPDR S&P Biotech ETF by 70.0% during the fourth quarter. WS Management Lllp now owns 130,000 shares of the exchange traded fund’s stock worth $15,851,000 after purchasing an additional 53,543 shares during the period. Integrated Advisors Network LLC lifted its stake in SPDR S&P Biotech ETF by 58.3% during the fourth quarter. Integrated Advisors Network LLC now owns 3,371 shares of the exchange traded fund’s stock worth $411,000 after purchasing an additional 1,242 shares during the period. Finally, AQR Capital Management LLC raised its stake in shares of SPDR S&P Biotech ETF by 39.6% in the fourth quarter. AQR Capital Management LLC now owns 10,314 shares of the exchange traded fund’s stock valued at $1,258,000 after acquiring an additional 2,926 shares during the last quarter.

SPDR S&P Biotech ETF Trading Up 3.0%

NYSEARCA:XBI opened at $139.39 on Thursday. SPDR S&P Biotech ETF has a 1 year low of $80.90 and a 1 year high of $141.82. The firm has a 50 day moving average of $133.12 and a 200-day moving average of $127.49. The stock has a market capitalization of $8.89 billion, a P/E ratio of 11.47 and a beta of 0.85.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.